Halozyme Therapeutics Quarterly Income Statements Chart
Quarterly
|
Annual
Halozyme Therapeutics Quarterly Income Statements Table
Quarterly
|
Annual
| Unit: USD | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | 2016-12-31 | 2016-09-30 | 2016-06-30 | 2016-03-31 | 2015-12-31 | 2015-09-30 | 2015-06-30 | 2015-03-31 | 2014-12-31 | 2014-09-30 | 2014-06-30 | 2014-03-31 | 2013-12-31 | 2013-09-30 | 2013-06-30 | 2013-03-31 | 2012-12-31 | 2012-09-30 | 2012-06-30 | 2012-03-31 | 2011-12-31 | 2011-09-30 | 2011-06-30 | 2011-03-31 | 2010-12-31 | 2010-09-30 | 2010-06-30 | 2010-03-31 | 2009-12-31 | 2009-09-30 | 2009-06-30 | 2009-03-31 | 2008-12-31 | 2008-09-30 | 2008-06-30 | 2008-03-31 | 2007-12-31 | 2007-09-30 | 2007-06-30 | 2007-03-31 | 2006-12-31 | 2006-09-30 | 2006-06-30 | 2006-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| revenues | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| royalties | 205,639,000 | 168,192,000 | 170,419,000 | 155,061,000 | 124,918,000 | 120,593,000 | 122,052,000 | 114,433,000 | 111,740,000 | 99,640,000 | 105,979,000 | 99,551,000 | 85,340,000 | 69,605,000 | 62,636,000 | 58,563,000 | 45,778,000 | 36,923,000 | 31,997,000 | 23,931,000 | 15,846,000 | 16,822,000 | 17,230,000 | 16,609,000 | 18,107,000 | 17,953,000 | 19,338,000 | 18,710,000 | 19,989,000 | 20,944,000 | 17,668,000 | 17,119,000 | 14,738,000 | 13,982,000 | 14,289,000 | 13,036,000 | 12,272,000 | 11,387,000 | 9,544,000 | 8,274,000 | 6,382,000 | 6,775,000 | 4,043,000 | 2,895,000 | 1,688,000 | 799,000 | ||||||||||||||||||||||||||||||||
| product sales | 81,510,000 | 78,041,000 | 79,364,000 | 86,659,000 | 78,886,000 | 58,583,000 | 79,602,000 | 86,569,000 | 73,889,000 | 60,794,000 | 61,163,000 | 61,427,000 | 46,300,000 | 22,140,000 | 27,051,000 | 25,047,000 | 30,360,000 | 21,766,000 | 32,455,000 | 9,048,000 | 6,337,000 | 8,147,000 | 22,693,000 | 29,205,000 | 5,760,000 | 8,390,000 | 10,681,000 | 6,269,000 | 4,483,000 | 6,801,000 | 12,593,000 | 13,589,000 | 12,780,000 | 11,434,000 | 13,422,000 | 13,331,000 | 13,699,000 | 12,940,000 | 13,579,000 | 10,301,000 | 12,342,000 | 9,860,000 | 10,144,000 | 9,617,000 | 9,494,000 | 8,568,000 | 9,806,375 | 10,024,902 | 3,099,853 | 1,508,594 | 1,459,735 | 715,354 | 524,942 | 187,411 | 348,280 | 1,156,903 | 165,470 | 397,810 | 226,251 | 411,109 | 199,530 | 397,810 | 478,781 | 267,901 | 179,951 | 78,207 | 219,871 | 267,901 | 82,727 | 141,438 | 98,170 | 185,252 | 169,082 | 187,086 | 115,205 | 362,477 | 119,662 | 73,281 |
| revenues under collaborative agreements | 38,570,000 | 18,628,000 | 48,225,000 | 48,364,000 | 27,549,000 | 16,703,000 | 28,385,000 | 15,031,000 | 35,409,000 | 1,709,000 | 14,354,000 | 47,998,000 | 20,725,000 | 25,534,000 | 12,316,000 | 32,220,000 | 60,317,000 | 30,333,000 | 57,251,000 | 32,337,000 | 33,038,000 | 385,000 | 13,742,000 | 416,000 | 15,281,000 | 30,606,000 | 30,213,000 | 577,000 | 10,730,000 | 3,127,000 | 159,303,000 | 33,023,000 | 6,232,000 | 4,152,000 | 11,292,000 | 5,486,000 | 7,365,000 | 18,172,000 | 29,104,000 | 2,205,000 | 24,660,000 | 2,031,000 | 16,190,000 | 2,094,000 | 7,203,000 | 2,599,000 | 2,692,558 | 5,988,262 | 11,353,957 | 10,324,946 | 20,333,814 | 4,618,969 | 7,232,233 | 7,252,768 | 2,062,887 | 21,785,525 | 23,023,478 | 3,043,921 | 6,170,452 | 2,617,776 | 3,013,823 | 3,043,921 | 1,302,474.25 | 2,194,325 | 1,351,492 | 1,664,080 | 480,048 | 757,629 | 539,434 | |||||||||
| total revenues | 325,719,000 | 264,861,000 | 298,008,000 | 290,084,000 | 231,353,000 | 195,879,000 | 230,039,000 | 216,033,000 | 221,038,000 | 162,143,000 | 181,496,000 | 208,976,000 | 152,365,000 | 117,279,000 | 102,003,000 | 115,830,000 | 136,455,000 | 89,022,000 | 121,703,000 | 65,316,000 | 55,221,000 | 25,354,000 | 53,665,000 | 46,230,000 | 39,148,000 | 56,949,000 | 60,232,000 | 25,556,000 | 35,202,000 | 30,872,000 | 189,564,000 | 63,731,000 | 33,750,000 | 29,568,000 | 39,003,000 | 31,853,000 | 33,336,000 | 42,499,000 | 52,227,000 | 20,780,000 | 43,384,000 | 18,666,000 | 30,377,000 | 14,606,000 | 18,385,000 | 11,966,000 | 12,498,933 | 16,013,164 | 14,453,810 | 11,833,540 | 21,793,549 | 5,334,323 | 7,757,175 | 7,440,179 | 2,411,167 | 22,942,428 | 23,188,948 | 3,441,731 | 6,396,703 | 3,028,885 | 3,213,353 | 3,441,731 | 7,969,342 | 2,462,226 | 1,426,156 | 2,772,371 | 3,062,176 | 2,462,226 | 1,434,219 | 1,805,518 | 1,337,909 | 942,881 | 708,516 | 810,215 | ||||
| operating expenses | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| cost of sales | 46,359,000 | 48,403,000 | 42,055,000 | 49,426,000 | 39,607,000 | 28,329,000 | 52,298,000 | 54,823,000 | 50,070,000 | 35,170,000 | 42,120,000 | 47,319,000 | 33,943,000 | 29,229 | 59,454 | 75,518 | 76,228 | 41,399 | 356,093 | 16,538 | 22,959 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| gross profit | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| yoy | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| qoq | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| gross margin % | 0% | 0% | 0% | 0% | 0% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| amortization of intangibles | 17,762,000 | 17,762,000 | 17,762,000 | 17,762,000 | 17,762,000 | 17,763,000 | 17,762,000 | 20,341,000 | 17,835,000 | 17,835,000 | 4,552,000 | 27,193,000 | 11,403,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| research and development | 17,543,000 | 14,799,000 | 20,441,000 | 18,458,000 | 21,038,000 | 19,111,000 | 21,336,000 | 17,321,000 | 19,727,000 | 17,979,000 | 22,566,000 | 16,705,000 | 15,483,000 | 11,853,000 | 10,108,000 | 8,486,000 | 8,069,000 | 9,009,000 | 7,380,000 | 7,747,000 | 8,951,000 | 10,158,000 | 45,111,000 | 30,455,000 | 33,910,000 | 31,328,000 | 36,650,000 | 35,540,000 | 40,086,000 | 37,976,000 | 41,376,000 | 33,993,000 | 38,339,000 | 36,935,000 | 41,349,000 | 33,863,000 | 35,530,000 | 40,100,000 | 27,746,000 | 27,611,000 | 21,195,000 | 16,684,000 | 19,728,000 | 19,904,000 | 18,649,000 | 21,415,000 | 20,925,194 | 25,689,189 | 27,990,755 | 22,034,437 | 18,567,744 | 19,503,491 | 16,081,729 | 15,891,109 | 14,916,205 | 13,514,352 | 15,347,116 | 11,467,204 | 10,009,532 | 13,162,748 | 11,924,406 | 11,467,204 | 29,163,812 | 10,080,775 | 14,561,137 | 14,040,087 | 16,782,482 | 10,080,775 | 8,925,488 | 8,444,191 | 7,288,460 | 6,352,397 | 4,083,885 | 2,829,364 | 2,678,748 | 2,429,016 | 1,914,925 | 2,192,070 |
| selling, general and administrative | 41,614,000 | 42,362,000 | 42,249,000 | 41,241,000 | 35,711,000 | 35,134,000 | 37,608,000 | 35,269,000 | 38,948,000 | 37,357,000 | 37,749,000 | 34,467,000 | 57,476,000 | 13,834,000 | 13,774,000 | 13,169,000 | 12,321,000 | 11,059,000 | 10,427,000 | 11,702,000 | 10,975,000 | 12,632,000 | 23,929,000 | 17,979,000 | 17,338,000 | 18,006,000 | 18,031,000 | 14,864,000 | 14,353,000 | 13,556,000 | 14,771,000 | 13,329,000 | 13,101,000 | 12,615,000 | 12,227,000 | 11,599,000 | 11,221,000 | 10,806,000 | 10,589,000 | 10,226,000 | 9,814,000 | 9,399,000 | 8,353,000 | 8,587,000 | 8,752,000 | 10,250,000 | 9,356,971 | 8,135,118 | 7,299,754 | 7,555,905 | 6,979,034 | 5,634,034 | 5,580,424 | 6,618,707 | 5,866,921 | 4,263,520 | 4,567,666 | 3,757,013 | 4,029,397 | 3,703,099 | 3,357,486 | 3,757,013 | 3,749,180 | 3,450,450 | 3,903,642 | 3,486,822 | 3,179,353 | 3,450,450 | 3,846,175 | 4,157,603 | 3,947,650 | 2,840,683 | 2,381,827 | 1,985,034 | 2,374,984 | 1,403,405 | 1,603,172 | 1,531,292 |
| total operating expenses | 123,278,000 | 123,326,000 | 122,507,000 | 126,887,000 | 114,118,000 | 100,337,000 | 129,004,000 | 127,754,000 | 126,580,000 | 108,341,000 | 106,987,000 | 125,684,000 | 118,305,000 | 41,609,000 | 45,469,000 | 40,244,000 | 43,408,000 | 38,287,000 | 44,079,000 | 25,017,000 | 25,666,000 | 28,577,000 | 85,727,000 | 70,767,000 | 53,125,000 | 53,983,000 | 60,303,000 | 51,030,000 | 55,275,000 | 54,584,000 | 63,635,000 | 55,654,000 | 59,228,000 | 57,094,000 | 61,578,000 | 54,596,000 | 55,059,000 | 58,668,000 | 46,762,000 | 44,017,000 | 39,153,000 | 32,577,000 | 34,228,000 | 33,632,000 | 33,325,000 | 37,185,000 | 33,822,293 | 34,507,020 | 36,574,458 | 30,329,313 | 26,200,662 | 25,364,160 | 21,805,273 | 22,580,577 | 20,839,285 | 17,789,595 | 20,093,017 | 15,229,877 | 14,872,273 | 16,968,485 | 15,365,431 | 15,229,877 | 33,019,847 | 13,661,945 | 18,509,876 | 17,531,113 | 20,089,123 | 13,661,945 | 12,808,789 | 12,638,984 | 11,265,339 | 9,252,534 | 6,541,230 | |||||
| operating income | 202,441,000 | 141,535,000 | 175,501,000 | 163,197,000 | 117,235,000 | 95,542,000 | 101,035,000 | 88,279,000 | 94,458,000 | 53,802,000 | 74,509,000 | 83,292,000 | 34,060,000 | 75,670,000 | 56,534,000 | 75,586,000 | 93,047,000 | 50,735,000 | 77,624,000 | 40,299,000 | 29,555,000 | -3,223,000 | -32,062,000 | -24,537,000 | -13,977,000 | 2,966,000 | -71,000 | -25,474,000 | -20,073,000 | -23,712,000 | 125,929,000 | 8,077,000 | -25,478,000 | -27,526,000 | -22,575,000 | -22,743,000 | -21,723,000 | -16,169,000 | 5,465,000 | -23,237,000 | 4,231,000 | -13,911,000 | -3,851,000 | -19,026,000 | -14,940,000 | -25,219,000 | -21,323,360 | -18,493,856 | -22,120,648 | -18,495,773 | -4,407,113 | -20,029,837 | -14,048,098 | -15,140,398 | -18,428,118 | 5,152,833 | 3,095,931 | -11,788,146 | -8,475,570 | -13,939,600 | -12,152,078 | -11,788,146 | -25,050,505 | -11,199,719 | -17,083,720 | -14,758,742 | -17,026,947 | -11,199,719 | -11,374,570 | -10,833,466 | -5,832,714 | |||||||
| yoy | 72.68% | 48.14% | 73.70% | 84.87% | 24.11% | 77.58% | 35.60% | 5.99% | 177.33% | -28.90% | 31.80% | 10.20% | -63.39% | 49.15% | -27.17% | 87.56% | 214.83% | -1674.15% | -342.11% | -264.24% | -311.45% | -208.66% | 45057.75% | -3.68% | -30.37% | -112.51% | -100.06% | -415.39% | -21.21% | -13.86% | -657.83% | -135.51% | 17.29% | 70.24% | -513.08% | -2.13% | -613.42% | 16.23% | -241.91% | 22.13% | -128.32% | -44.84% | -81.94% | 2.88% | -32.46% | 36.35% | 383.84% | -7.67% | 57.46% | 22.16% | -76.08% | -488.72% | -553.76% | 28.44% | 117.43% | -136.97% | -125.48% | 0.00% | -66.17% | 24.46% | -28.87% | -20.13% | 47.12% | 0.00% | 50.19% | 36.23% | 95.01% | |||||||||||
| qoq | 43.03% | -19.35% | 7.54% | 39.21% | 22.71% | -5.44% | 14.45% | -6.54% | 75.57% | -27.79% | -10.54% | 144.54% | -54.99% | 33.85% | -25.21% | -18.77% | 83.40% | -34.64% | 92.62% | 36.35% | -1017.00% | -89.95% | 30.67% | 75.55% | -571.24% | -4277.46% | -99.72% | 26.91% | -15.35% | -118.83% | 1459.11% | -131.70% | -7.44% | 21.93% | -0.74% | 4.70% | 34.35% | -395.86% | -123.52% | -649.21% | -130.41% | 261.23% | -79.76% | 27.35% | -40.76% | 18.27% | 15.30% | -16.40% | 19.60% | 319.68% | -78.00% | 42.58% | -7.21% | -17.84% | -457.63% | 66.44% | -126.26% | 39.08% | -39.20% | 14.71% | 3.09% | -52.94% | 123.67% | -34.44% | 15.75% | -13.32% | 52.03% | -1.54% | 4.99% | |||||||||
| operating margin % | 0% | 0% | 0% | 0% | 0% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| other income | 135,007 | 175,000 | 182,182 | 182,846 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| investment and other income | 6,891,000 | 6,818,000 | 7,253,000 | 6,474,000 | 5,032,000 | 4,993,000 | 5,360,000 | 4,786,000 | 3,192,000 | 2,979,000 | 852,000 | 641,000 | -945,000 | 498,000 | 331,000 | 274,000 | 221,000 | 276,000 | 661,000 | 961,000 | 1,324,000 | 2,479,000 | 1,333,000 | 1,613,000 | 1,983,000 | 2,057,000 | 2,017,000 | 1,910,000 | 1,983,000 | 1,668,000 | 1,080,000 | 790,000 | 435,000 | 287,000 | 366,000 | 334,000 | 397,000 | 229,000 | 155,000 | 78,000 | 87,000 | 102,000 | -45,000 | 122,000 | 118,000 | 47,000 | 64,685 | 51,424 | 58,132 | 54,988 | ||||||||||||||||||||||||||||
| interest expense | -4,394,000 | -4,525,000 | -4,540,000 | -4,524,000 | -4,524,000 | -4,507,000 | -5,220,000 | -4,505,000 | -4,494,000 | -4,543,000 | -4,570,000 | -7,514,000 | -3,104,000 | -1,759,000 | -2,055,000 | -1,754,000 | -1,752,000 | -1,965,000 | -5,036,000 | -4,990,000 | -5,004,000 | -5,348,000 | -3,731,000 | -2,078,000 | -2,613,000 | -3,205,000 | -3,755,000 | -4,286,000 | -4,770,000 | -5,230,000 | -5,458,000 | -5,538,000 | -5,540,000 | -5,448,000 | -5,599,000 | -5,253,000 | -5,249,000 | -3,876,000 | -1,302,000 | -1,301,000 | -1,299,000 | -1,299,000 | -1,378,000 | -1,376,000 | -1,451,000 | -1,376,000 | -727,628 | -849,936 | -848,995 | -847,584 | ||||||||||||||||||||||||||||
| income before income tax expense | 204,938,000 | 143,828,000 | 178,214,000 | 165,147,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| income tax expense | 39,778,000 | 25,733,000 | 41,202,000 | 28,136,000 | 24,498,000 | 19,205,000 | 12,737,000 | 19,923,000 | 18,402,000 | 12,623,000 | 7,326,000 | 14,301,000 | 58,000 | 191,000 | 33,000 | 63,000 | 58,000 | 11,000 | 13,000 | 13,000 | 17,000 | 22,000 | 55,000 | 33,000 | 187,000 | 242,500 | 580,000 | 180,000 | 210,000 | -422,000 | 1,284,000 | 300,000 | ||||||||||||||||||||||||||||||||||||||||||||||
| net income | 165,160,000 | 118,095,000 | 137,012,000 | 137,011,000 | 93,245,000 | 76,823,000 | 85,388,000 | 81,837,000 | 74,754,000 | 39,615,000 | 57,702,000 | 61,634,000 | 22,685,000 | 60,108,000 | 66,770,000 | 216,587,000 | 91,458,000 | 27,895,000 | 73,164,000 | 36,207,000 | 25,817,000 | -6,103,000 | -34,397,000 | -25,015,000 | -14,624,000 | 1,796,000 | -2,126,000 | -27,850,000 | -22,893,000 | -27,461,000 | 123,882,000 | 2,749,000 | -30,763,000 | -32,897,000 | -27,386,000 | -28,946,000 | -26,875,000 | -19,816,000 | 4,318,000 | -24,460,000 | 3,019,000 | -15,108,000 | -5,274,000 | -20,280,000 | -16,273,000 | -26,548,000 | -21,986,303 | -19,292,368 | -22,911,511 | -19,288,369 | -4,405,856 | -20,005,846 | -14,021,119 | -15,119,181 | -18,415,614 | 5,165,193 | 3,116,288 | -11,787,477 | -7,545,979 | -13,910,282 | -12,150,923 | -11,787,477 | -26,531,978 | -10,872,158 | -17,060,025 | -14,725,364 | -16,825,654 | -10,872,158 | -11,002,390 | -9,953,997 | -8,708,391 | -7,028,782 | -4,801,707 | -3,357,304 | -4,377,963 | -3,651,037 | -3,232,791 | -3,490,194 |
| yoy | 77.12% | 53.72% | 60.46% | 67.42% | 24.74% | 93.92% | 47.98% | 32.78% | 229.53% | -34.09% | -13.58% | -71.54% | -75.20% | 115.48% | -8.74% | 498.19% | 254.25% | -557.07% | -312.70% | -244.74% | -276.54% | -439.81% | 1517.92% | -10.18% | -36.12% | -106.54% | -101.72% | -1113.10% | -25.58% | -16.52% | -552.36% | -109.50% | 14.47% | 66.01% | -734.23% | 18.34% | -990.20% | 31.16% | -181.87% | 20.61% | -118.55% | -43.09% | -76.01% | 5.12% | -28.97% | 37.64% | 399.02% | -3.57% | 63.41% | 27.58% | -76.08% | -487.32% | -549.93% | 28.26% | 144.05% | -137.13% | -125.65% | 0.00% | -71.56% | 27.94% | -28.78% | -19.95% | 57.69% | 0.00% | 55.06% | 47.93% | 93.21% | 54.68% | 129.13% | 196.49% | 98.91% | 92.51% | 48.53% | -3.81% | ||||
| qoq | 39.85% | -13.81% | 0.00% | 46.94% | 21.38% | -10.03% | 4.34% | 9.48% | 88.70% | -31.35% | -6.38% | 171.69% | -62.26% | -9.98% | -69.17% | 136.82% | 227.87% | -61.87% | 102.07% | 40.24% | -523.02% | -82.26% | 37.51% | 71.05% | -914.25% | -184.48% | -92.37% | 21.65% | -16.63% | -122.17% | 4406.44% | -108.94% | -6.49% | 20.12% | -5.39% | 7.71% | 35.62% | -558.92% | -117.65% | -910.20% | -119.98% | 186.46% | -73.99% | 24.62% | -38.70% | 20.75% | 13.96% | -15.80% | 18.78% | 337.79% | -77.98% | 42.68% | -7.26% | -17.90% | -456.53% | 65.75% | -126.44% | 56.21% | -45.75% | 14.48% | 3.08% | -55.57% | 144.04% | -36.27% | 15.85% | -12.48% | 54.76% | -1.18% | 10.53% | 14.30% | 23.90% | 46.38% | 43.02% | -23.31% | 19.91% | 12.94% | -7.38% | |
| net income margin % | -4.80% | -465.21% | -5.82% | -5.23% | -5.77% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| earnings per share | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| basic | 1.36 | 0.96 | 1.08 | 1.08 | 0.73 | 0.61 | 0.65 | 0.62 | 0.57 | 0.29 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| diluted | 1.33 | 0.93 | 1.06 | 1.05 | 0.72 | 0.6 | 0.65 | 0.61 | 0.56 | 0.29 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| weighted-average common shares outstanding | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| basic | 121,343 | 123,215 | 126,827 | 126,850 | 127,116 | 126,941 | 131,927 | 131,965 | 131,730 | 135,027 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| diluted | 124,158 | 126,644 | 129,424 | 130,134 | 129,222 | 128,887 | 134,197 | 134,083 | 133,543 | 137,900 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| contingent liability fair value measurement gain | 13,200,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| net income before income taxes | 117,743,000 | 96,028,000 | 101,175,000 | 101,760,000 | 93,156,000 | 52,238,000 | 70,791,000 | 73,707,000 | 30,011,000 | 74,409,000 | 54,810,000 | 74,106,000 | 91,516,000 | 28,086,000 | 73,249,000 | 36,270,000 | 25,875,000 | -6,092,000 | -9,447,750 | -25,002,000 | -14,607,000 | 1,818,000 | -19,496,000 | -27,850,000 | -22,860,000 | -27,274,000 | -30,583,000 | -32,687,000 | -27,808,000 | -27,662,000 | -26,575,000 | |||||||||||||||||||||||||||||||||||||||||||||||
| inducement expense related to convertible notes | -2,712,000 | -20,960,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| revenues: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| operating expenses: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| other income: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| income tax benefit | 13,089,000 | 12,073,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| net income per share | -0.05 | -0.07 | -0.06 | -0.05 | -0.06 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| basic | 0.43 | 0.45 | 0.16 | 0.44 | 0.47 | 1.53 | 0.64 | 0.2 | 0.54 | 0.27 | 0.19 | -0.04 | 0.01 | -0.01 | -0.19 | 0.91 | 0.02 | -0.21 | 0.02 | -0.003 | 0.05 | 0.03 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| diluted | 0.42 | 0.44 | 0.16 | 0.43 | 0.46 | 1.48 | 0.62 | 0.19 | 0.51 | 0.25 | 0.19 | -0.04 | 0.01 | -0.01 | -0.19 | 0.9 | 0.02 | -0.21 | 0.02 | -0.003 | 0.05 | 0.03 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| shares used in computing net income per share: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| basic | -526 | 136,527 | 137,937 | 137,658 | -169 | 142,021 | 142,487 | 137,952 | -369 | 136,578 | 135,935 | 137,186 | 144,743 | 203 | 143,949 | 1,786 | 141,190 | 127,958 | 126,144 | 27,664,689.25 | 112,305,002 | 112,063,665 | 25,570,726 | 103,223,352 | 102,671,410 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| diluted | -411 | 139,387 | 142,216 | 141,277 | -856 | 146,690 | 147,624 | 148,540 | 1,492 | 142,081 | 138,084 | 137,186 | 147,474 | 203 | 143,949 | 4,435 | 143,236 | 127,958 | 134,507 | 27,664,689.25 | 112,305,002 | 112,063,665 | 25,570,726 | 105,009,189 | 104,393,835 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| cost of product sales | 15,922,000 | 21,587,000 | 18,589,000 | 23,018,000 | 18,219,000 | 26,272,000 | 5,568,000 | 5,740,000 | 5,787,000 | 16,687,000 | 22,333,000 | 1,877,000 | 4,649,000 | 5,622,000 | 626,000 | 836,000 | 3,052,000 | 7,488,000 | 8,332,000 | 7,788,000 | 7,544,000 | 8,002,000 | 9,134,000 | 8,308,000 | 7,762,000 | 8,427,000 | 6,180,000 | 8,144,000 | 6,494,000 | 6,147,000 | 5,141,000 | 5,924,000 | 5,520,000 | 3,540,128 | 682,713 | 1,283,949 | 738,971 | 653,884 | 226,635 | 143,120 | 70,761 | 56,159 | 11,723 | 178,235 | 5,660 | 833,344 | 102,638 | 83,539 | 5,660 | 106,855 | 130,720 | 45,097 | 4,204 | 127,288 | 130,720 | 37,126 | 37,190 | |||||||||||||||||||||
| income tax (benefit) expense | -11,960,000 | -142,481,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| net income per share | -0.05 | -0.07 | -0.06 | -0.05 | -0.06 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| basic and diluted | -0.065 | -0.17 | -0.1 | -0.16 | -0.19 | -0.23 | -0.26 | -0.148 | -0.23 | -0.16 | -0.073 | -0.19 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| shares used in computing net income per share: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| basic and diluted | 36,358.75 | 146,136 | 145,411 | 143,568 | 142,656 | 134,013 | 128,615 | 31,971.5 | 128,154 | 127,615 | 31,531.75 | 126,921 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| income before income taxes | 121,551,000 | 3,329,000 | -3,490,194 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| basic and diluted net income per share | -0.12 | -0.04 | -0.16 | -0.13 | -0.22 | -0.19 | -0.17 | -0.2 | -0.17 | -0.04 | -0.18 | -0.13 | -0.14 | -0.13 | -0.02 | -0.16 | -0.13 | -0.13 | -0.27 | -0.14 | -0.21 | -0.18 | -0.21 | -0.14 | -0.14 | -0.13 | -0.11 | -0.09 | -0.07 | |||||||||||||||||||||||||||||||||||||||||||||||||
| shares used in computing basic and diluted net income per share | 125,299 | 533 | 124,041 | 123,710 | 118,943 | 250,992 | 112,765,155 | 112,486,211 | 112,416,792 | 107,589,514 | 91,610,830 | 9,271,239 | 89,570,540 | 91,766,799 | 91,610,830 | 7,316,480 | 80,293,800 | 82,990,107 | 82,429,868 | 460,093 | 80,293,800 | 79,454,496 | 78,300,319 | 1,058,800 | 76,502,867 | 73,217,967 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| interest and other income | 18,046.75 | 23,991 | 26,979 | 21,217 | 14,146.5 | 12,360 | 20,357 | 669 | 21,597.75 | 29,318 | 1,155 | 669 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| comprehensive income | -12,286,536.5 | -20,005,846 | -14,021,119 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| comprehensive loss | -15,119,181 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| revenues under collaboration agreements | 1,302,474.25 | 2,194,325 | 1,246,205 | 2,694,164 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| interest income | -1,481,473 | 327,561 | 23,695 | 33,378 | 138,293 | 327,561 | 372,180 | 879,469 | 1,219,039 | 1,280,871 | 1,031,007 | 723,107 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| income from operations | -4,555,694.25 | -8,309,653 | -4,080,411 | -4,668,805 | -3,826,037 | -3,414,973 | -3,673,040 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| revenue under collaborative agreements | 623,129 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| expenses: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| total expenses | 4,890,626 | 5,095,131 | 4,188,514 | 3,534,635 | 3,746,321 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| net income per share | -0.05 | -0.07 | -0.06 | -0.05 | -0.06 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| shares used in computing net income per share, basic and diluted | 69,984,931 | 941,064 | 62,731,254 | 61,841,867 | 60,456,462 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
We provide you with 20 years income statements for Halozyme Therapeutics stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as earnings, sales and marketing expenses, research and development costs, profits, and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Halozyme Therapeutics stock. Explore the full financial landscape of Halozyme Therapeutics stock with our expertly curated income statements.
The information provided in this report about Halozyme Therapeutics stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.